Secondary Prevention Education After Acute Myocardial Infarction
NCT ID: NCT04769219
Last Updated: 2024-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
86 participants
INTERVENTIONAL
2020-03-01
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Training Methods for a Doctrine Of Life With Healthy Heart
NCT00738231
Effect of Health Belief Model-Based Education
NCT07047950
The Effect Of Education Given According to Meleıs' Transitional Theory to Patients With Pacemaker
NCT06204601
Impact of Education and Text Messages on Cardiovascular Disease Risk Factors Awareness Knowledge and Quality of Life
NCT06537856
Myocardial Infarction
NCT06948123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
secondary prevention training
Secondary prevention training will be given to 43 randomly selected patients between the fourth and sixth hours after AMI (in accordance with the patient's request). Secondary protection training will be carried out in two parts. First of all, the anatomical structure and functions of the heart, the definition of AMI, its causes, symptoms and risk factors will be explained, and then the issues to be considered after AMI will be explained. The content of the training will also be given to the participants in a written booklet.
Secondary prevention training
Secondary prevention training will be given after acute myocardial infarction
nursing care
43 randomly selected patients will form the control group and this group will be provided with routine care and follow-up in the clinic. No intervention will be made.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Secondary prevention training
Secondary prevention training will be given after acute myocardial infarction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not having received training after AMI \*
* Being 18 years or older,
* Speak Turkish,
* No problem in verbal communication,
* Absence of hearing loss,
* Not being diagnosed with a psychiatric illness,
* Being conscious,
* Being volunteer to participate in the study,
* Routine check of cholesterol, HDL, LDL, triglyceride results at the beginning of the study and at 6 months.
Exclusion Criteria
* Having received training after AMI
* Not willing to participate in the study,
* Cannot speak Turkish,
* Problems in verbal communication,
* Having hearing loss,
* Having a diagnosis of psychiatric illness,
* Unconsciousness.
* Cholesterol, HDL, LDL, triglyceride results were not routinely checked at the start and 6 months of the study.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abant Izzet Baysal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
saadet can çiçek, Dr
Role: PRINCIPAL_INVESTIGATOR
Abant Izzet Baysal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abant İzzet Baysal University
Merkez, Bolu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AIBU-KYB-AYN-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.